Learning the Lessons of Antitumour Necrosis Factor Therapy-Associated Psoriasis
Psoriasis or psoriasiform skin lesions, as an adverse effect of treatment with antitumor necrosis factor antibody therapy, have been described relatively recently. Patients with these lesions have no personal or family history of psoriasis. In a small number of cases, an association with Chlamydia h...
Saved in:
| Main Authors: | Matt Shale, Subrata Ghosh |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2009-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/2009/514618 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of antitumour necrosis factor therapy on surgery in inflammatory bowel disease: a population-based study
by: Richard C G Pollok, et al.
Published: (2024-07-01) -
Antitumour necrosis factor-α agents and development of new-onset cirrhosis or non-alcoholic fatty liver disease: a retrospective cohort
by: Susan Hutfless, et al.
Published: (2020-12-01) -
Resynthesis of synthetic biology techniques: combining engineered bacteria with other antitumour therapies
by: Xueke Chang, et al.
Published: (2025-07-01) -
Incidence of Toxoplasmosis in Psoriasis Patients and Possible Correlation with Tumor Necrosis Factor-α
by: Entsar J. Saheb, et al.
Published: (2020-03-01) -
Antitumour Activity of Dehydroxymethylepoxyquinomycin (DHMEQ): a Literature Review
by: K. Umezawa, et al.
Published: (2021-04-01)